Search research articles
Contact Us
Filters
Showing results (51-60 of 157) with videos related to
Page
of 16
Sort By:
Alimentary Pharmacology & Therapeutics
|
June 26, 2024
Letter: Persisting with persistence-A caution as an outcome measure in inflammatory bowel disease: Authors' reply
Tsz Hong Yiu, Yanna Ko, Aviv Pudipeddi, et al.
Journal of Crohn'S & Colitis
|
February 28, 2020
Ulcerative Colitis and Cytomegalovirus Infection: From A to Z
Fadi H Mourad, Jana G Hashash, Viraj C Kariyawasam, et al.
World Journal of Gastrointestinal Endoscopy
|
July 18, 2025
Endocytoscopy in real-time assessment of histological and endoscopic activity in ulcerative colitis
Thanaboon Chaemsupaphan, Mohammad Shir Ali, Caroline Fung, et al.
Alimentary Pharmacology & Therapeutics
|
April 23, 2024
Meta-analysis: Persistence of advanced therapies in the treatment of inflammatory bowel disease
Tsz Hong Yiu, Yanna Ko, Aviv Pudipeddi, et al.
Expert Review of Clinical Immunology
|
June 29, 2023
Real-world experience with subcutaneous infliximab: broadening treatment strategies for inflammatory bowel disease
Philip J Smith, Mathurin Fumery, Rupert W Leong, et al.
Alimentary Pharmacology & Therapeutics
|
May 23, 2024
Letter: Early real-world evidence from the United Arab Emirates of the persistence, effectiveness and safety of risankizumab for the treatment of Crohn's disease-Authors' reply
Tsz Hong Yiu, Yanna Ko, Aviv Pudipeddi, et al.
United European Gastroenterology Journal
|
November 1, 2014
Outcomes of single-dose peri-procedural antibiotic prophylaxis for endoscopic ultrasound-guided fine-needle aspiration of pancreatic cystic lesions
Emmanuel Marinos, Sunny Lee, Brian Jones, et al.
Therapeutic Advances in Gastroenterology
|
March 31, 2022
Gastroenterology team members' knowledge and practices with fertility therapy for women with inflammatory bowel disease
Robyn Laube, Eleanor Liu, Ying Li, et al.
Expert Opinion on Drug Safety
|
November 13, 2015
Safety of proton pump inhibitors and risk of gastric cancers: review of literature and pathophysiological mechanisms
Yanna Ko, James Tang, Santosh Sanagapalli, et al.
Scandinavian Journal of Gastroenterology
|
June 14, 2022
Low-dose IL-2 may enhance the effect of vedolizumab
Cheng Hiang Lee, Sarah Huang, Peter Hsu, et al.
Page
of 16
Search research articles
Search
Showing results (51-60 of 157) with videos related to
Sort By:
Page
of 16
Alimentary Pharmacology & Therapeutics
|
June 26, 2024
Letter: Persisting with persistence-A caution as an outcome measure in inflammatory bowel disease: Authors' reply
Tsz Hong Yiu, Yanna Ko, Aviv Pudipeddi, et al.
Journal of Crohn'S & Colitis
|
February 28, 2020
Ulcerative Colitis and Cytomegalovirus Infection: From A to Z
Fadi H Mourad, Jana G Hashash, Viraj C Kariyawasam, et al.
World Journal of Gastrointestinal Endoscopy
|
July 18, 2025
Endocytoscopy in real-time assessment of histological and endoscopic activity in ulcerative colitis
Thanaboon Chaemsupaphan, Mohammad Shir Ali, Caroline Fung, et al.
Alimentary Pharmacology & Therapeutics
|
April 23, 2024
Meta-analysis: Persistence of advanced therapies in the treatment of inflammatory bowel disease
Tsz Hong Yiu, Yanna Ko, Aviv Pudipeddi, et al.
Expert Review of Clinical Immunology
|
June 29, 2023
Real-world experience with subcutaneous infliximab: broadening treatment strategies for inflammatory bowel disease
Philip J Smith, Mathurin Fumery, Rupert W Leong, et al.
Alimentary Pharmacology & Therapeutics
|
May 23, 2024
Letter: Early real-world evidence from the United Arab Emirates of the persistence, effectiveness and safety of risankizumab for the treatment of Crohn's disease-Authors' reply
Tsz Hong Yiu, Yanna Ko, Aviv Pudipeddi, et al.
United European Gastroenterology Journal
|
November 1, 2014
Outcomes of single-dose peri-procedural antibiotic prophylaxis for endoscopic ultrasound-guided fine-needle aspiration of pancreatic cystic lesions
Emmanuel Marinos, Sunny Lee, Brian Jones, et al.
Therapeutic Advances in Gastroenterology
|
March 31, 2022
Gastroenterology team members' knowledge and practices with fertility therapy for women with inflammatory bowel disease
Robyn Laube, Eleanor Liu, Ying Li, et al.
Expert Opinion on Drug Safety
|
November 13, 2015
Safety of proton pump inhibitors and risk of gastric cancers: review of literature and pathophysiological mechanisms
Yanna Ko, James Tang, Santosh Sanagapalli, et al.
Scandinavian Journal of Gastroenterology
|
June 14, 2022
Low-dose IL-2 may enhance the effect of vedolizumab
Cheng Hiang Lee, Sarah Huang, Peter Hsu, et al.
Page
of 16